Published in Drug Week, October 20th, 2006
"This trial was performed to determine the MTD of radiation that can be administered with carboplatin and paclitaxel. This trial included 15 patients with unresectable non-small-cell lung cancer. Paclitaxel (50 mg/m2) and carboplatin (area under the curve=2) were given weekly during RT," researchers in the United States reported.
"The RT included 2 Gy...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.